Home » Market News » DirectorsTalk Highlights » What is CBD? The science behind the controversial cannabis extract
Sativa Investments plc

What is CBD? The science behind the controversial cannabis extract

From croissants to lubricants, CBD oil is being added to a huge range of weird and wonderful products.

But while it is a term you’ve probably heard banded about, what actually is CBD?

To help separate the fact from the fiction, Dr David Dawit, Chief Scientific Officer of Eos Scientific, spoke to Mirror Online about CBD.

Sativa Investments (NEX:SATI) is the UK’s first medicinal cannabis investment vehicle. After investing in two North American businesses, it is now progressing a UK seed to consumer investment strategy with 100% ownership of businesses involved in the production, testing and compliance, research & development including pharmacology, commercialisation and sales & marketing of medicinal cannabis and cannabidiol products. Two UK businesses, George Botanicals and PhytoVista Laboratories, are already fully operational.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.